long-acting insulins such as insulinglargine and insulin detemir), making it a once-daily basal insulin, that is one that provides a base insulin level, as
(Human insulin), for type 1 and type 2 diabetes mellitus. Lantus (insulinglargine), for type 1 and type 2 diabetes mellitus. Soliqua (insulinglargine/lixisenatide)
approved. 2000 Sanofi Aventis Lantus insulin "glargine" analogue approved for clinical use in the US and the EU. 2004 Sanofi Aventis Apidra insulin "glulisine"